Clinical trial
Assessment of Chimerism and Relapse Post Bone Marrow/HCT Transplant Using AlloHeme Test (ACROBAT)
NCT04635384 is registered in ClinicalTrials.gov with CareDx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Chimerism and Relapse Post Bone Marrow/HCT Transplant Using AlloHeme Test (ACROBAT)
- Lead sponsor
- CareDx
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 30, 2021
- Completion date
- November 30, 2026
- Enrollment
- 307 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, acute myeloid leukemia, myelodysplastic syndrome